(Q77352461)
Statements
A double-masked, placebo-controlled evaluation of 0.5% loteprednol etabonate in the treatment of postoperative inflammation. The Loteprednol Etabonate Postoperative Inflammation Study Group 2 (English)
1 September 1998
scientific article published on 01 September 1998